COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)
Recruiting · NCT05258448 · Observational (researchers observe without assigning treatment) · Lead sponsor: Odense University Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Chemoradiotherapy
What this trial is about
Patients with loco-regional NSCLC planned for curative treatment with chemoradiotherapy will be invited to participate in a prospective study; besides routine treatment, the patients will be followed with an ECG and cardiac MR for at least two years after radiotherapy treatment.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age ≥ 18 Years
- Inoperable and histologically/cytologically verified NSCLC.
- Planned treatment with curative intent.
- Capable of completing study procedures ECG and Cardiac MR.
- Able of giving written and informed consent before study procedures are initiated.
Exclusion criteria
- Vulnerable patients.
- Patients with operable devices as pacemaker/ICD and cochlear implant or other conditions where MR scan is contraindicated.
- Claustrophobia.
Where it is running
1 location listed.
- Odense University Hospital - Odense C, Denmark